Caricamento...
Acneiform rash during lung cancer therapy with erlotinib (Tarceva(®))
Tyrosine kinase inhibitors are currently applied in the treatment of non-small cell lung cancer with overexpressed epidermal growth factor receptor (EGFR). Acneiform rash is the earliest and most characteristic side effect of EGFR inhibition. The incidence may be as high as 50-100% of cases. We repo...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Termedia Publishing House
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3834717/ https://ncbi.nlm.nih.gov/pubmed/24278074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pdia.2013.35624 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|